Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rafael Holdings ( (RFL) ) just unveiled an announcement.
Rafael Holdings, Inc. has issued 1,078,796 warrants, exercisable for 380,253 shares of its Class B common stock, as part of a merger with Cyclo Therapeutics, Inc. These warrants, listed on the NYSE American under the symbol ‘RFL-WT,’ were exchanged for Cyclo’s existing warrants and are set to expire on December 11, 2025.
The most recent analyst rating on (RFL) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Rafael Holdings stock, see the RFL Stock Forecast page.
Spark’s Take on RFL Stock
According to Spark, TipRanks’ AI Analyst, RFL is a Underperform.
Rafael Holdings is facing significant challenges with profitability and cash flow, which are reflected in its financial performance score. The technical analysis indicates a bearish trend, with the stock trading below key moving averages and technical indicators suggesting oversold conditions. The valuation is unattractive due to a negative P/E ratio and lack of dividend yield. These factors collectively result in a low overall stock score.
To see Spark’s full report on RFL stock, click here.
More about Rafael Holdings
Average Trading Volume: 121,356
Technical Sentiment Signal: Sell
Current Market Cap: $63.16M
For a thorough assessment of RFL stock, go to TipRanks’ Stock Analysis page.

